Puretech Health Plc Stock Performance
| PRTC Stock | USD 16.64 0.35 2.06% |
The company holds a Beta of 0.7, which implies possible diversification benefits within a given portfolio. As returns on the market increase, PureTech Health's returns are expected to increase less than the market. However, during the bear market, the loss of holding PureTech Health is expected to be smaller as well. At this point, PureTech Health PLC has a negative expected return of -0.17%. Please make sure to check PureTech Health's total risk alpha, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if PureTech Health PLC performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days PureTech Health PLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest conflicting performance, the Stock's basic indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders. ...more
Actual Historical Performance (%)
One Day Return 3.06 | Five Day Return 0.94 | Year To Date Return 3.06 | Ten Year Return (55.45) | All Time Return (55.45) |
1 | REG - PureTech Health PLC - Holding in Company - TradingView | 10/17/2025 |
2 | Will PureTech Health plc stock issue positive guidance - 2025 Sector Review Consistent Profit Trading Strategies - newser.com | 10/23/2025 |
3 | Can PureTech Health plc Depositary Receipt stock hit analyst price targets - July 2025 WrapUp Community Trade Idea Sharing - Fundao Cultural do Par | 10/27/2025 |
4 | Can PureTech Health plc Depositary Receipt stock outperform in 2025 bull market - Inflation Watch Real-Time Chart Pattern Alerts - newser.com | 11/04/2025 |
5 | Operating cash flow per share of PureTech Health PLC BER0VQ - TradingView | 12/03/2025 |
6 | PureTech Announces Successful End-of-Phase 2 Meeting with FDA for Deupirfenidone in Idiopathic Pulmonary Fibrosis | 12/08/2025 |
7 | How PureTech Health plc stock behaves under inflation pressure - July 2025 EndofMonth Weekly High Return Stock Forecasts - | 12/19/2025 |
| Begin Period Cash Flow | 191.1 M | |
| Total Cashflows From Investing Activities | 240.9 M |
PureTech Health Relative Risk vs. Return Landscape
If you would invest 1,898 in PureTech Health PLC on October 6, 2025 and sell it today you would lose (234.00) from holding PureTech Health PLC or give up 12.33% of portfolio value over 90 days. PureTech Health PLC is currently does not generate positive expected returns and assumes 2.6947% risk (volatility on return distribution) over the 90 days horizon. In different words, 24% of stocks are less volatile than PureTech, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
PureTech Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for PureTech Health's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as PureTech Health PLC, and traders can use it to determine the average amount a PureTech Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0641
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | PRTC |
Based on monthly moving average PureTech Health is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of PureTech Health by adding PureTech Health to a well-diversified portfolio.
PureTech Health Fundamentals Growth
PureTech Stock prices reflect investors' perceptions of the future prospects and financial health of PureTech Health, and PureTech Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on PureTech Stock performance.
| Return On Equity | 0.0944 | ||||
| Return On Asset | -0.13 | ||||
| Profit Margin | 7.93 % | ||||
| Operating Margin | (25.90) % | ||||
| Current Valuation | 105.07 M | ||||
| Shares Outstanding | 24.17 M | ||||
| Price To Book | 1.07 X | ||||
| Price To Sales | 63.23 X | ||||
| Revenue | 4.83 M | ||||
| Gross Profit | (48.81 M) | ||||
| EBITDA | 37.38 M | ||||
| Net Income | 27.78 M | ||||
| Cash And Equivalents | 368.03 M | ||||
| Cash Per Share | 12.84 X | ||||
| Total Debt | 22.36 M | ||||
| Debt To Equity | 0.08 % | ||||
| Current Ratio | 2.54 X | ||||
| Book Value Per Share | 1.56 X | ||||
| Cash Flow From Operations | (134.37 M) | ||||
| Earnings Per Share | 1.70 X | ||||
| Market Capitalization | 404.1 M | ||||
| Total Asset | 602.63 M | ||||
| Retained Earnings | 32.49 M | ||||
| Working Capital | 344.87 M | ||||
About PureTech Health Performance
By analyzing PureTech Health's fundamental ratios, stakeholders can gain valuable insights into PureTech Health's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if PureTech Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if PureTech Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 83.26 | 87.42 | |
| Return On Tangible Assets | 0.08 | 0.08 | |
| Return On Capital Employed | (0.28) | (0.26) | |
| Return On Assets | 0.08 | 0.08 | |
| Return On Equity | 0.15 | 0.09 |
Things to note about PureTech Health PLC performance evaluation
Checking the ongoing alerts about PureTech Health for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for PureTech Health PLC help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| PureTech Health PLC generated a negative expected return over the last 90 days | |
| PureTech Health PLC currently holds about 368.03 M in cash with (134.37 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 12.84. | |
| Latest headline from news.google.com: How PureTech Health plc stock behaves under inflation pressure - July 2025 EndofMonth Weekly High Return Stock Forecasts - |
- Analyzing PureTech Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether PureTech Health's stock is overvalued or undervalued compared to its peers.
- Examining PureTech Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating PureTech Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of PureTech Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of PureTech Health's stock. These opinions can provide insight into PureTech Health's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for PureTech Stock analysis
When running PureTech Health's price analysis, check to measure PureTech Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PureTech Health is operating at the current time. Most of PureTech Health's value examination focuses on studying past and present price action to predict the probability of PureTech Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PureTech Health's price. Additionally, you may evaluate how the addition of PureTech Health to your portfolios can decrease your overall portfolio volatility.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |